← Altimmune
Episodes featuring Altimmune
3 episodes, newest first.
- Nov 15, 2026
Biotech investors weigh gene editing, MASH data and RAS riskBreaking BiotechNov 15, 2026 - Oct 10, 2026
Biotech ETFs frame a week of company-specific movesBreaking BiotechOct 10, 2026 - Aug 18, 2026
Cadence faces the AI disruption test as Cramer weighs market fearsMad Money w/ Jim CramerAug 18, 2026